mitoguazone
Term · Oncology and biomedicine · MLC-T-ONC-015207
A guanylhydrazone with potential antineoplastic activity. Mitoguazone competitively inhibits S-adenosyl-L-methionine decarboxylase (SAMD), an enzyme involved in the synthesis of polyamines, resulting in decreased proliferation of tumor cells, antimitochondrial effects, and p53-independent apoptosis. Polyamines, specifically spermine and spermidine, are essential for thymidine kinase production, DNA synthesis, and cell proliferation.
| Identifier | MLC-T-ONC-015207 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | MGBG |
| Synonyms | methylglyoxal bisguanylhydrazone; mitoguazone dihydrochloride; pyruvaldehyde bis(amidinohydrazone) |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015207",
"term": "mitoguazone",
"field": "Oncology and biomedicine",
"definition": "A guanylhydrazone with potential antineoplastic activity. Mitoguazone competitively inhibits S-adenosyl-L-methionine decarboxylase (SAMD), an enzyme involved in the synthesis of polyamines, resulting in decreased proliferation of tumor cells, antimitochondrial effects, and p53-independent apoptosis. Polyamines, specifically spermine and spermidine, are essential for thymidine kinase production, DNA synthesis, and cell proliferation.",
"abbreviation": "MGBG",
"synonyms": [
"methylglyoxal bisguanylhydrazone",
"mitoguazone dihydrochloride",
"pyruvaldehyde bis(amidinohydrazone)"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/mitoguazone/"
}
Record 11,113 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.